';

Meditrial provides rapid workflows to rescue clinical trials during pandemic

March 19, 2020

As the COVID-19 emergency impacts all healthcare sectors, Meditrial provides rapid tools to help industry and researchers rescue their clinical trials. Safeguard of patients’ safety is the key concern, but also avoiding the compromised integrity of important studies due to missing data and deviations from scientific protocols.

The Meditrial solutions are designed to assist sponsors in assuring the safety of trial participants, maintaining compliance with good clinical practice and minimizing risks to trial integrity. The Meditrial team is trained to addresses all challenges such as:

  • quarantines
  • site closures
  • travel limitations
  • interruptions to the supply chain for the investigational product
  • extra support if site personnel or trial subjects become infected with SARS-CoV-2.

 

 

Meditrial can help, Contact us now

Meditrial has developed rapid workflows to conduct risk assessment, implement rescue plans and execute solutions:

Contact Meditrial for immediate assistance in Europe or the US. Free Helpline +1-800-901-4286 helpline@meditrial.net

Recommend
  • Facebook
  • Twitter
  • LinkedIN
Share